Home ›
Uterine Cancer Trials ›
NCT04845828
Randomized Comparison Between Sentinel Lymph Node Biopsy and Lymph Node Dissection in Early Stage Endometrial Cancer
Through this clinical trial, the investigators aim to verify the usefulness and stability of sentinel lymph node mapping in endometrial cancer of clinical stage I-II.
Trial Details
NCT ID NCT04845828
Phase NA
Sponsor Asan Medical Center
Status RECRUITING
Cancer Type Uterine Cancer
Interventions Sentinel lymph node mapping Routine lymph node dissection
Locations (sample) Seoul, South Korea|37.566,126.9784
Key Eligibility Criteria
20 \~ 80 years old female histologically diagnosed endometrial cancer that has never been treated before. histological type :endometrioid, mucinous, serous, clear cell, uindifferentiated, dedifferentiated, mesonephric adenocarcinoma, mesonephric-like ad… histological grade : FIGO grade 1, 2, 3
For full eligibility, visit ClinicalTrials.gov .
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Uterine Cancer Trials on Trialify →